Patent: 9,254,321
Summary for Patent: 9,254,321
| Title: | Compositions and methods for stabilizing protein-containing formulations |
| Abstract: | The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof. |
| Inventor(s): | Osigwe Esue, Vikas K. Sharma |
| Assignee: | Genentech Inc |
| Application Number: | US13/722,559 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,254,321
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | RAPTIVA | efalizumab | Injection | 125075 | October 27, 2003 | 9,254,321 | 2032-12-20 |
| Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST | rilonacept | For Injection | 125249 | February 27, 2008 | 9,254,321 | 2032-12-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,254,321
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2011270828 | ⤷ Start Trial |
| Brazil | 112012033002 | ⤷ Start Trial |
| Canada | 2802756 | ⤷ Start Trial |
| Canada | 3111727 | ⤷ Start Trial |
| China | 103068367 | ⤷ Start Trial |
| European Patent Office | 2585045 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
